Delivery Order SPE2DB20D3103-SPE2DB26FL4E8
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,357.98 to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM on August 5, 2025, with an ultimate completion date of August 6, 2025. This delivery order represents a firm fixed price transaction with no set-aside designation, performed at the contractor's location in Conshohocken, Pennsylvania. The award was competitively awarded and falls under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a $2,204.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Cortifoam 10% Aerosol 15GM on September 17, 2025, with an ultimate completion date of September 18, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. The award was made through open competition with...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of CORTIFOAM 10% AEROSOL 15GM medical products. The contract has a ceiling value of $15,332.04 and a period of performance through September 24, 2024. The contract is a firm-fixed price delivery order, with no set-aside designation. Amerisourcebergen, through its extensive supply chain network, will provide these critical medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $3,656.64 for the supply of 4561599390 CORTIFOAM 10% AEROSOL 15GM. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of July 26, 2023. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating it was awarded through full and open competition. Amerisourcebergen Drug...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $2,764.08 by the Medical Supply Chain division of the Defense Logistics Agency on September 4, 2025, with an ultimate completion date of September 5, 2025. The contract involves the supply of Proctofoam-HC 1%-1% Foam in 10-gram units, a topical pharmaceutical product. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $2,432.56 delivery order from the Defense Logistics Agency (DLA) on October 29, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a firm fixed-price, non-set-aside contract with an ultimate completion date of October 30, 2025. The delivery order will be performed in Conshohocken, Pennsylvania, and represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a $1,034.22 firm fixed-price delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for Proctofoam-HC 1%-1% Foam in a 10-gram unit. This is a non-set-aside competitive award with a completion date of September 11, 2025, and represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a $2,863.20 firm fixed price delivery order to AmerisourceBergen Drug Corp for Proctofoam-HC 1%-1% Foam in a 10-gram quantity. Awarded on August 15, 2025, with an ultimate completion date of August 18, 2025, this non-set-aside contract represents a small-value medical supply procurement. The work will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's larger...
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 18, 2025, for Proctofoam-HC 1%-1% Foam (10gm), a pharmaceutical product with a ceiling value of $7,073.70. This firm fixed price delivery order, with an ultimate completion date of September 19, 2025, represents a non-competitive set-aside contract and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is a child...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, has been awarded a competitively-bid delivery order valued at $8,804.04 by the Defense Medical Supply Chain on May 23, 2025, for the procurement of Proctofoam 10GM 1S, a topical pharmaceutical product. The delivery order represents a firm fixed-price contract with an ultimate completion date of May 27, 2025, and carries no set-aside designation. This award is structured as a child contract, likely issued under...
- SPE2DB20D3103Indefinite Delivery Contract
- SPE2DB20D3103-SPE2DB26FL4E8Delivery Order
AmerisourceBergen Drug Corp was awarded a delivery order valued at $1,653.36 by the Defense Logistics Agency on October 28, 2025, for the supply of Cortifoam 10% Aerosol 15GM. This competitively awarded, firm fixed-price delivery order is scheduled for completion by October 29, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award carries no set-aside designation. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen Drug Corp maintains an extensive portfolio of federal contract awards encompassing brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains in support of the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Loading... | ||||